Inspire Medical Systems (INSP) Long-Term Deferred Tax (2024 - 2026)

Inspire Medical Systems has disclosed Long-Term Deferred Tax across 3 years of filings, most recently posting $87.7 million for Q1 2026.

• Long-Term Deferred Tax for Q1 2026 came in at $87.7 million, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $87.7 million (changed N/A YoY), and the FY2025 annual result was $88.7 million, up 681953.85% from the prior year.
• Long-Term Deferred Tax came in at $87.7 million for Q1 2026 at Inspire Medical Systems, down from $88.7 million in the prior quarter.
• In the past five years, Long-Term Deferred Tax ranged from a high of $88.7 million in Q4 2025 to a low of $13000.0 in Q4 2024.
• The 3-year median for Long-Term Deferred Tax is $87.7 million (2026), against an average of $58.8 million.
• Peak annual rise in Long-Term Deferred Tax reached 681953.85% in 2025, while the deepest fall reached 681953.85% in 2025.
• Inspire Medical Systems' Long-Term Deferred Tax stood at $13000.0 in 2024, then jumped by 681953.85% to $88.7 million in 2025, then dropped by 1.13% to $87.7 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $87.7 million (Q1 2026), $88.7 million (Q4 2025), and $13000.0 (Q4 2024), per Business Quant data.